Provenge Tops 500 Scripts Since Approval; Most Local Medicare Contractors Will Cover Product
This article was originally published in The Pink Sheet Daily
Executive Summary
Dendreon gave an update on the launch of the prostate cancer vaccine during its earnings call on Aug. 3.